1. Início
  2. Faculdade de Medicina - FM
  3. Departamento de Cardiopneumologia - FM/MCP
  4. Artigos e Materiais de Revistas Científicas - FM/MCP
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1837
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorOLIVEIRA-CARVALHO, Vagner-
dc.contributor.authorSILVA, Miguel Morita Fernandes da-
dc.contributor.authorGUIMARAES, Guilherme Veiga-
dc.contributor.authorBACAL, Fernando-
dc.contributor.authorBOCCHI, Edimar Alcides-
dc.date.accessioned2013-09-23T16:36:38Z-
dc.date.available2013-09-23T16:36:38Z-
dc.date.issued2013-
dc.identifier.citationMOLECULAR BIOLOGY REPORTS, v.40, n.3, p.2663-2670, 2013-
dc.identifier.issn0301-4851-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1837-
dc.description.abstractMicroRNAs (miRNAs) are a class of non-coding small RNAs representing one of the most exciting areas of modern medical science. miRNAs modulate a large and complex regulatory network of gene expression of the majority of the protein-coding genes. Currently, evidences suggest that miRNAs play a crucial role in the pathogenesis of heart failure. Some miRNAs as miR-1, miR-133 and miR-208a are highly expressed in the heart and strongly associated with the development of cardiac hypertrophy. Recent data indicate that these miRNAs as well as miR-206 change their expression quickly in response to physical activity. The differential regulation of miRNAs in response to exercise suggests a potential value of circulating miRNAs (c-miRNAs) as biomarkers of physiological mediators of the cardiovascular adaptation induced by exercise. Likewise, serum levels of c-miRNAs such as miR-423-5p have been evaluated as potential biomarkers in the diagnosis and prognosis of heart failure. On the other hand, the manipulation of miRNAs levels using techniques such as 'miR mimics' and 'antagomiRs' is becoming evident the enormous potential of miRNAs as promising therapeutic strategies in heart failure.-
dc.language.isoeng-
dc.publisherSPRINGER-
dc.relation.ispartofMolecular Biology Reports-
dc.rightsrestrictedAccess-
dc.subjectMicroRNAs-
dc.subjectHeart failure-
dc.subjectExercise-
dc.subject.otherhuman skeletal-muscle-
dc.subject.otheracute myocardial-infarction-
dc.subject.othercardiac-hypertrophy-
dc.subject.othercirculating micrornas-
dc.subject.othergene-expression-
dc.subject.otherresistance exercise-
dc.subject.othermessenger-rna-
dc.subject.otherin-vivo-
dc.subject.otherbiomarker-
dc.subject.otherdisease-
dc.titleMicroRNAs: new players in heart failure-
dc.typearticle-
dc.rights.holderCopyright SPRINGER-
dc.identifier.doi10.1007/s11033-012-2352-y-
dc.identifier.pmid23242657-
dc.subject.wosBiochemistry & Molecular Biology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage2663-
hcfmusp.description.endpage2670-
hcfmusp.description.issue3-
hcfmusp.description.volume40-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84878421000-
hcfmusp.origem.idWOS:000314535600065-
hcfmusp.publisher.cityDORDRECHT-
hcfmusp.publisher.countryNETHERLANDS-
hcfmusp.relation.referenceAdachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121-
hcfmusp.relation.referenceBaggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363-
hcfmusp.relation.referenceBeuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118-
hcfmusp.relation.referenceCallis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154-
hcfmusp.relation.referenceCare A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582-
hcfmusp.relation.referenceOliveira-Carvalho V, 2012, ARQ BRAS CARDIOL, V98, P362, DOI 10.1590/S0066-782X2012000400011-
hcfmusp.relation.referenceCordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195-
hcfmusp.relation.referenceDavidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010-
hcfmusp.relation.referenceDe Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572-
hcfmusp.relation.referenceDowning J, 2011, J AM COLL CARDIOL, V58, P561, DOI 10.1016/j.jacc.2011.04.020-
hcfmusp.relation.referenceDrummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008-
hcfmusp.relation.referenceElia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429-
hcfmusp.relation.referenceFang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107-
hcfmusp.relation.referenceFichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566-
hcfmusp.relation.referenceGregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085-
hcfmusp.relation.referenceHan M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d-
hcfmusp.relation.referenceHill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139-
hcfmusp.relation.referenceIkeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007-
hcfmusp.relation.referenceJi X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310-
hcfmusp.relation.referenceKatare R, 2011, CIRC RES, V109, P894, DOI 10.1161/CIRCRESAHA.111.251546-
hcfmusp.relation.referenceKim GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006161-
hcfmusp.relation.referenceKim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925-
hcfmusp.relation.referenceKrutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303-
hcfmusp.relation.referenceLi Dong, 2010, J Hypertens, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922-
hcfmusp.relation.referenceLiu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708-
hcfmusp.relation.referenceMatkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576-
hcfmusp.relation.referenceMatkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176-
hcfmusp.relation.referenceMcCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009-
hcfmusp.relation.referenceMontgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932-
hcfmusp.relation.referenceNielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860-
hcfmusp.relation.referencePina Ileana L., 2003, Circulation, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40-
hcfmusp.relation.referenceRadom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009-
hcfmusp.relation.referenceRen XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145-
hcfmusp.relation.referenceRingholm S, 2011, AM J PHYSIOL-ENDOC M, V301, pE649, DOI 10.1152/ajpendo.00230.2011-
hcfmusp.relation.referenceSayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23-
hcfmusp.relation.referenceSilva MMF, 2012, ARQ BRAS CARDIOL, V98, P459-
hcfmusp.relation.referenceSmits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282-
hcfmusp.relation.referenceStelzer JE, 2007, J PHYSIOL-LONDON, V579, P161, DOI 10.1113/jphysiol.2006.119719-
hcfmusp.relation.referenceSucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI [10.1016/j.yjmcc.2008.04.014, 10.1016/j.yjmcc.2009.04.014]-
hcfmusp.relation.referenceSuckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852-
hcfmusp.relation.referenceThum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947-
hcfmusp.relation.referenceThum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511-
hcfmusp.relation.referenceTijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297-
hcfmusp.relation.referenceTimmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19-
hcfmusp.relation.referenceTownley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002-
hcfmusp.relation.referencevan Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013-
hcfmusp.relation.referencevan Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103-
hcfmusp.relation.referenceWang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013-
hcfmusp.relation.referenceWeber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045-
hcfmusp.relation.referenceWidera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011-
hcfmusp.relation.referenceZhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007-
hcfmusp.relation.referenceZhao T, 2010, AM J PHYSIOL-ENDOC M, V299, P110-
hcfmusp.relation.referenceZhu H., 2011, AM J CARDIOVASC DIS, V1, P138-
hcfmusp.relation.referenceZhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus56-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação


Files in This Item:
File Description SizeFormat 
art_OLIVEIRA-CARVALHO_MicroRNAs_new_players_in_heart_failure_2013.PDF
  Restricted Access		publishedVersion (English)218.21 kBAdobe PDFView/Open Request a copy
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.